Portage Biotech 株価情報 (NASDAQ: PRTG)

最新ニュース Portage Biotech (NASDAQ:PRTG) 株価情報

Portage Biotech

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.

Portage Biotech Inc

Citizens Capital Markets analyst Greg Miller reiterates SBA Comms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBAC#NASDAQ">SBAC</a>) with a Market Outperform and maintains $250 price target.

News

Price Target

Reiteration

Analyst Ratings

SBAC

Citizens Capital Markets Reiterates Market Outperform on SBA Comms, Maintains $250 Price Target

Truist Securities analyst Patrick Scholes reiterates Ryman Hospitality Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHP#NYSE">RHP</a>) with a Buy and lowers the price target from $136 to $133.

Truist Securities Reiterates Buy on Ryman Hospitality Props, Lowers Price Target to $133

Macro Economic Events

WIIM

Economics

Oil is trading lower. The commodity may be under pressure amid President Trump's Russia-Ukraine policies as well as US economic concerns, which could affect demand outlook. Additionally, US crude inventories rose last week.

Dan&nbsp;Loeb‘s&nbsp;Third Point LLC, which has a varied mix of stock from across the sectors, did some major portfolio restructuring in the <a target="_blank" href="https://www.benzinga.com/topic/dan-loeb" rel="noreferrer noopener">last quarter of 2024</a>.
According to recent 13F filings,&nbsp;reflecting his holding as of Dec. 31, 2024, Loeb slashed a stake in the major Life Sciences Tools &amp; Services company Danaher Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) <a target="_blank" href="https://www.sec.gov/Archives/edgar/data/1040273/000108514625001713/xslForm13F_X02/infotable.xml" rel="noreferrer noopener">to </a>1,900,000 from 1,950,000 shares <a target="_blank" href="https://www.sec.gov/Archives/edgar/data/1040273/000108514624005927/xslForm13F_X02/infotable.xml" rel="noreferrer noopener">in </a>the third quarter of 2024, a decline of around 2.5%.
Notably, the investor has been cutting stake in Danaher in the last couple of quarters. Earlier, he held 2,050,000 shares <a target="_blank" href="https://www.sec.gov/Archives/edgar/data/1040273/000108514624004004/xslForm13F_X02/infotable.xml" rel="noreferrer noopener">as </a>of second quarter of 2024 and 2,450,000 shares as <a target="_blank" href="https://www.sec.gov/Archives/edgar/data/1040273/000108514623004511/xslForm13F_X02/infotable.xml" rel="noreferrer noopener">of </a>third quarter of 2023.
Instead, the investor acquired a stake in Danaher&#8217;s major peer Thermo Fisher Scientific Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>), attaining 350,000 shares in the fourth quarter 2024.
Read: <a target="_blank" href="https://www.benzinga.com/25/02/43861240/repligens-q4-earnings-beat-2025-guidance-highlights-market-growth" rel="noreferrer noopener">Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook</a>
DHR Major Events:
<ul>
<li>In January, the company reported weaker-than-expected fourth-quarter earnings, with adjusted earnings per share of $2.14 missing the street view of $2.16 and sales of $6.54 billion (+2%), beating the analyst <a href="https://www.benzinga.com/news/earnings/25/01/43298036/danaher-q4-eps-miss-expectations-amid-diagnostics-segment-lag" target="_blank" rel="noreferrer noopener">consensus estimate of $6.42 billion</a>.</li>
<li>Danaher expects its non-GAAP core revenue to decline by a low-single digit percentage year-over-year in the first quarter. However, it anticipates a 3% year-over-year increase in <a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener">core revenue for the full year of 2025</a>.</li>
<li>Following the earnings release, several analysts cut the price forecast on the stock, with Barclays analyst Luke Sergott lowering the price forecast from $275 to $240 and Wells Fargo analyst Brandon Couillard curtailing the price target from $280 to $240 and <a href="https://www.benzinga.com/25/01/43336758/danaher-analysts-cut-their-forecasts-after-downbeat-earnings" target="_blank" rel="noreferrer noopener">both maintaining an Equal-Weight</a>.</li>
<li>This month, Danaher raised quarterly dividend <a href="https://www.benzinga.com//node/43866316" target="_blank" rel="noreferrer noopener">per share from&nbsp;$0.27&nbsp;to&nbsp;$0.32</a>.</li>
</ul>
TMO Major Events:
<ul>
<li>Last month, the company reported fourth-quarter adjusted earnings per share of $6.10, beating the street view of $5.94 and sales of $11.395 billion (+5% year over year) outpaced the analyst <a href="https://www.benzinga.com/25/01/43337781/thermo-fisher-q4-earnings-beat-estimates-margin-expands" target="_blank" rel="noreferrer noopener">consensus estimate of $11.277 billion</a>.</li>
<li>Following the earnings release, several analysts raised the price forecast on the stock, with Morgan Stanley analyst Tejas Savant increasing the price target from&nbsp;$647&nbsp;to&nbsp;$678 and Wells Fargo analyst Brandon Couillard upped <a href="https://www.benzinga.com/quote/TMO/analyst-ratings" target="_blank" rel="noreferrer noopener">the price forecast from&nbsp;$660&nbsp;to&nbsp;$680</a>.</li>
<li>This month, Thermo Fisher Scientific raised its quarterly dividend<a href="https://www.benzinga.com//node/43830343" target="_blank" rel="noreferrer noopener"> from $0.39 to $0.43 per share</a>.</li>
<li>Thermo Fisher inked a 10-year VPPA with X-ELIO to enhance renewable energy access in pharmaceutical and healthcare supply chains through the Lorca solar project, set to launch <a href="https://www.benzinga.com/pressreleases/25/02/b43460138/thermo-fisher-scientific-accelerates-100-percent-renewable-electricity-goal-for-european-operation" target="_blank" rel="noreferrer noopener">in early 2026 with three industry partners</a>.</li>
</ul>
Year to date, Danaher shares declined around 10% while Thermo Fisher rose 0.66%, both underperforming the iShares U.S. Healthcare ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYH#NYSE">IYH</a>), which gained about 5%&nbsp;over the same time frame.
Also, the companies top peers Agilent Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) fell roughly 0.3% and IQVIA Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>) declined about 1.3% so far this year.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/25/02/43796723/dan-loebs-third-point-boosts-meta-holdings-now-a-top-4-position" target="_blank" rel="noreferrer noopener">Dan Loeb&#8217;s Third Point Boosts Meta Holdings, Now A Top 4 Position</a></li>
</ul>
Photo: Shutterstock

Equities

Large Cap

ETFs

iShares Trust Dow Jones US Healthcare Sector Index Fund

Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favor

Citizens Capital Markets analyst Karol Chmiel reiterates ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) with a Market Outperform and maintains $20 price target.

Citizens Capital Markets Reiterates Market Outperform on ProAssurance, Maintains $20 Price Target

Citizens Capital Markets analyst Nicholas Jones reiterates Offerpad Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OPAD#NYSE">OPAD</a>) with a Market Outperform and maintains $4.5 price target.

OPAD

Citizens Capital Markets Reiterates Market Outperform on Offerpad Solutions, Maintains $4.5 Price Target

NRG Energy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>) short percent of float has fallen 29.47% since its last report. The company recently reported that it has 6.30 million shares sold short, which is 4.14% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.62 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>NRG Energy Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740498327_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for NRG Energy has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing NRG Energy's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, NRG Energy's peer group average for short interest as a percentage of float is 2.00%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

What Does the Market Think About NRG Energy?

Cogent Comms Hldgs's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCOI#NYSE">CCOI</a>) short percent of float has fallen 8.3% since its last report. The company recently reported that it has 3.45 million shares sold short, which is 11.05% of all regular shares that are available for trading. Based on its trading volume, it would take traders 11.73 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Cogent Comms Hldgs Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740498322_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Cogent Comms Hldgs has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Cogent Comms Hldgs's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Cogent Comms Hldgs's peer group average for short interest as a percentage of float is 6.22%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

CCOI

Peering Into Cogent Comms Hldgs's Recent Short Interest

SharkNinja's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SN#NYSE">SN</a>) short percent of float has fallen 10.19% since its last report. The company recently reported that it has 3.55 million shares sold short, which is 5.73% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.3 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>SharkNinja Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740498317_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for SharkNinja has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing SharkNinja's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, SharkNinja's peer group average for short interest as a percentage of float is 7.67%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

What Does the Market Think About SharkNinja?

Marathon Petroleum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPC#NYSE">MPC</a>) has outperformed the market over the past 5 years by 12.07% on an annualized basis producing an average annual return of 26.01%. Currently, Marathon Petroleum has a market capitalization of $48.75 billion. 
Buying $100 In MPC: If an investor had bought $100 of MPC stock 5 years ago, it would be worth $319.84 today based on a price of $151.67 for MPC at the time of writing.
<h3>Marathon Petroleum's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740498308_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

Citizens Capital Markets analyst Matthew Carletti maintains Goosehead Insurance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSHD#NASDAQ">GSHD</a>) with a Market Outperform and raises the price target from $125 to $150.

GSHD

Citizens Capital Markets Maintains Market Outperform on Goosehead Insurance, Raises Price Target to $150

Options

Markets

Petrobras Brasileiro Option Alert: Jun 20 $14 Calls at the Ask: 5500 @ $1.08 vs 16690 OI; Earnings 2/26 After Close Ref=$14.515

Citizens Capital Markets analyst Mitch Germain reiterates Gaming and Leisure Props (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLPI#NASDAQ">GLPI</a>) with a Market Outperform and maintains $55 price target.

GLPI

Citizens Capital Markets Reiterates Market Outperform on Gaming and Leisure Props, Maintains $55 Price Target

Barclays analyst Eddie Kim maintains Noble Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NE#NYSE">NE</a>) with a Overweight and lowers the price target from $43 to $39.

Barclays Maintains Overweight on Noble Corp, Lowers Price Target to $39

Shares of Carnival Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) and other cruise companies came under pressure last week amid concerns around a <a href="https://www.benzinga.com/25/02/43867330/cruise-stocks-drop-amid-us-tax-crackdown-concerns-whats-going-on">tax crackdown in the US</a>.
While demand in Europe remains strong, a potential ceasefire between Russia and Ukraine could boost the overall cruise industry, according to JPMorgan.
The Carnival Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/586bcbd9351b9b0001ab738c/matthew-boss">Analyst Matthew Boss</a> maintained an Overweight rating and price target of $31.
The Carnival Thesis: Checks indicate "zero signs of Europe softening," with continued robust demand and 2025 pricing up by mid-to-high single digits, Boss said in the note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
The cruise industry's booked positions were strong entering the year and occupancy levels are returning to historical levels, he added.
The overall sentiment for global travel is positive, with a potential ceasefire between Russia and Ukraine providing "the next leg of yield strength," the analyst stated.
Carnival could be the "next cruise operator out of the Big 3" to resume shareholder returns, Boss said.
If Carnival begins by reinstating dividends, it could generate around $5 billion in free cash flow post-dividend during 2026-2027, which would "translate to mgmt being able to buyback ~10-15% of its outstanding shares," he further wrote.
CCL Price Action: Shares of Carnival were down 1% to $23.36 at the time of publication on Tuesday.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/25/01/42922091/spacex-apple-airbnb-and-more-companies-pitch-in-to-support-california-residents-after-wildfires-we-want-to-help"> Carnival Corp&#8217;s Private Island Strategy Poised For Significant Expansion, Says Analyst</a></li>
</ul>
Photo: Shutterstock

Travel

Carnival Analyst Sees 'Zero Signs Of Europe Softening' Amid Strong Demand, 2025 Pricing Rise

Citizens Capital Markets analyst Jonathan Wolleben reiterates BioCryst Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCRX#NASDAQ">BCRX</a>) with a Market Outperform and maintains $18 price target.

BCRX

Citizens Capital Markets Reiterates Market Outperform on BioCryst Pharma, Maintains $18 Price Target

First Solar Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) will be reporting its fourth-quarter earnings on Tuesday. Wall Street expects $4.71 in EPS and $1.47 billion in revenues as the company reports<a href="https://www.benzinga.com/calendars/earnings?tickers=FSLR" target="_blank" rel="noreferrer noopener"> after market hours</a>.
The stock is up 5.76% over the past year, down 18% YTD.
Let&#8217;s look at what the charts indicate for First Solar stock and how the stock currently maps against Wall Street estimates.
Read Also: <a href="https://www.benzinga.com/news/earnings/25/02/43929653/first-solar-q4-earnings-preview-sales-net-bookings-to-watch">First Solar Q4 Earnings Preview: Sales, Net Bookings To Watch</a>
<h2 class="wp-block-heading">First Solar Strongly Bearish Ahead Of Q4 Earnings</h2>
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022525&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="627" height="493" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25092133/Screenshot-2025-02-25-at-7.46.11-PM.png" alt="" class="wp-image-797592" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25092133/Screenshot-2025-02-25-at-7.46.11-PM.png 627w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25092133/Screenshot-2025-02-25-at-7.46.11-PM-300x236.png 300w" sizes="(max-width: 627px) 100vw, 627px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022525&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
First Solar stock is firmly in bearish territory, with its stock, at $152.91, trading below its five, 20, and 50-day exponential moving averages. This alignment signals strong selling pressure and raises the risk of continued bearish movement. The stock's eight-day simple moving average (SMA) of $159.56 and 20-day SMA of $162.91 both reinforce the bearish outlook, as FSLR stock struggles to regain upward momentum.
Further compounding the negative trend, First Solar's 50-day SMA stands at $177.05, while the 200-day SMA is at $211.45, both significantly above the current share price. 
The Moving Average Convergence Divergence (MACD) indicator at a negative 5.71 adds to the bearish sentiment, while the Relative Strength Index (RSI) of 33.06 suggests the stock is nearing oversold territory but not yet at a reversal point.
For investors, the technical setup suggests caution, with the bearish trend likely to persist unless the stock breaks above key resistance levels. A bullish outlook would require a reversal above the 20-day SMA, while continued weakness could push FSLR stock toward lower support levels.
<h2 class="wp-block-heading">First Solar Analysts See 67% Upside</h2>
Ratings &amp; Consensus Estimates:<a href="https://www.benzinga.com/quote/FSLR/analyst-ratings" target="_blank" rel="noreferrer noopener"> The consensus analyst rating</a> on First Solar stock stands at a Buy currently with a price target of $278.71. Recent ratings from Mizuho, BofA Securities and Barclays suggest a 67.05% upside for First Solar stock with a $256 average price target.
Price Action: First Solar stock was trading at $153.25 at the time of publication.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/02/43938959/trump-targets-chinas-tech-sector-with-stricter-biden-era-chip-curbs-it-will-backfire-says-beijing">Trump Reportedly Targets China&#8217;s Tech Sector With Stricter Biden-Era Chip Curbs. It Will Backfire, Says Beijing</a></li>
</ul>
Image: Shutterstock

Technicals

Previews

Tech

FSLR

First Solar Stock Loses Power Ahead Of Q4 Earnings, Analysts Still See 67% Upside

Scotiabank analyst Ovais Habib maintains Pan American Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAAS#NYSE">PAAS</a>) with a Sector Outperform and raises the price target from $28 to $28.5.

PAAS

Scotiabank Maintains Sector Outperform on Pan American Silver, Raises Price Target to $28.5

Citizens Capital Markets analyst Daniel Stauder reiterates Artivion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AORT#NYSE">AORT</a>) with a Market Outperform and maintains $33 price target.

AORT

Citizens Capital Markets Reiterates Market Outperform on Artivion, Maintains $33 Price Target

SPDR Dow Jones Industrial Average ETF Trust

Major indexes are lower following weaker-than-expected February consumer confidence data, which has added to recent concerns over US consumer and economic health.

Comments

Portage Biotech

ニュース

最新ニュース Portage Biotech (NASDAQ:PRTG) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル